<DOC>
	<DOCNO>NCT01874483</DOCNO>
	<brief_summary>To investigate safety , tolerability , pharmacokinetics pharmacodynamics BI 187004 follow multiple dose administration 14 day .</brief_summary>
	<brief_title>Safety , Tolerability , Pharmacokinetics Pharmacodynamics Multiple Rising Doses BI 187004 Patients With Type 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Inclusion criterion : 1 . Type 2 diabetes mellitus 2 . Current treatment one antidiabetic drug ( except insulin GLP1 analogue ) 3 . Males postmenopausal surgically sterilise female 4 . Age 20 70 year 5 . HbA1c le equal 8.5 % 6 . BMI 2840 kg/m2 7 . Subjects must able understand comply study requirement Exclusion criterion : 1 . Any finding medical examination ( include BP , PR ECG ) deviate normal investigator considers acceptable clinical relevance 2 . Repeated measurement systolic blood pressure great 160 mm Hg diastolic blood pressure great 95 mm Hg 3 . Myocardial infarction , stroke transient ischemic attack within 6 month prior inform consent 4 . Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder besides type 2 diabetes , hyperlipidaemia medically treat hypertension 5 . Surgery gastrointestinal tract might affect absorption elimination study drug 6 . Diseases central nervous system ( epilepsy ) psychiatric disorder relevant neurological disorder besides polyneuropathy 7 . Chronic relevant acute infection ( e.g . HIV , hepatitis )</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>